Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis

Published:2013-11 Issue: Volume:1537 Page:267-272
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Braidy Nady,Lim Chai K.,Grant Ross,Brew Bruce J.,Guillemin Gilles J.

Funder

National Health & Medical Research Council of Australia Capacity Building

UNSW Faculty of Medicine Research Grant

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference38 articles.

1. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration;Arraki;Science,2004

2. The new life of a centenarian: signalling functions of NAD(P);Berger;Trends Biochem. Sci.,2004

3. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms;Berger;J. Biol. Chem.,2005

4. An improved cycling assay for nicotinamide adenine dinucleotide;Bernofsky;Anal. Biochem.,1973

5. PARP-1, a determinant of cell survival in response to DNA damage;Bouchard;Experimental Hematology,2003

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials;Journal of Nanobiotechnology;2023-12-13

2. Evidence of Brain Target Engagement in Parkinson’s Disease and Multiple Sclerosis by the Investigational Nanomedicine, CNM-Au8, in the REPAIR Phase 2 Clinical Trials;2023-11-07

3. Brain Target Engagement by CNM-Au8 in Parkinson’s Disease and Multiple Sclerosis: Integrated Imaging Results from the REPAIR-PD and REPAIR-MS Phase 2 Clinical Trials;2023-07-19

4. Glucose metabolic reprogramming in autoimmune diseases;Animal Cells and Systems;2023-07-16

5. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives;IBRO Neuroscience Reports;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3